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Introduction

Clinical Case (continued)

Hepatic hydrothorax (HH) is a difficult-tocontrol complication of cirrhosis. Chest tube
(CT) drainage is an option for management of
HH, but is associated with a high rate of
secondary infection and other complications.

Figure 1. Initial Coronal
CT Chest reconstruction
demonstrating right
sided empyema with
thickened pleura (arrow)
with trapped lung.

Clinical Case
A 35 year old male with hepatitis C cirrhosis was
transferred to our hospital for management of
HH. Prior to transfer, a pleurex catheter was
placed because he required serial
thoracenteses.
At our hospital, a trial of aggressive diuresis was
unsuccessful, so he underwent transjugular
intrahepatic portosystemic shunt (TIPS).
However, drainage from the catheter continued
at 1 to 1.5 liters daily, and further diuresis was
limited by hyponatremia. With a MELD score of
24 and refractory HH, liver transplant (OLT) was
clearly indicated. However, shortly after TIPS,
pleural fluid culture grew methicillin-resistant
S. aureus. He was treated with antibiotics, and
his pleurex catheter was removed, but chest
computed tomography showed multifocal
pneumonia, persistent multiloculated effusion,
and trapped lung(fig. 1).
He was treated with tissue plasminogen
activator infusion via new CTs, but his trapped
lung did not resolve.

Figure 2.
Post decortication
Coronal CT Chest
reconstruction
demonstrating
improvement in lung
aeration.

Bacterial culture of further pleural fluid
samples remained without growth, and he was
discharged with a plan to complete a 6-week
course of vancomycin, with his CTs in place.
Less than two weeks later, the patient was readmitted with encephalopathy. Repeat
diagnostic thoracentesis yielded a new culture
growing E. coli. Consensus after extensive
multidisciplinary discussion was that resolution
of his infection and trapped lung was no longer
realistic, and OLT impossible, without surgical
intervention. Therefore, he underwent open
thoracotomy with decortication. A repeat chest
computerized tomography at 3 weeks postprocedure showed that the empyema had
resolved and lung aeration improved (Fig.2).

Clinical Case (continued)
Persistently high post-operative CT output
combined with hyponatremia made it very
difficult to remove his four CTs, the final CT
being removed on post-op day 56. He was
discharged with a plan to complete an
outpatient OLT evaluation.
Unfortunately, the patient resumed using illicit
drugs, precluding further consideration for OLT.
He was later readmitted with renal failure, and
died approximately 6 months after his initial
presentation. However, his empyema was
ultimately not what limited his survival.

Discussion 	
  
The initial management of hepatic hydrothorax
should focus on dietary sodium restriction and
medical therapy with diuretics. Serial
thoracentesis is an effective method for
controlling hepatic hydrothorax when medical
therapy with diuretics is insufficient.
For selected candidates, trans-hepatic portosystemic shunt (TIPS) placement may be an
alternative to serial thoracentesis. However,
not all patients are candidates for TIPS with
contra-indications to the procedure including
renal failure, right heart failure, and advanced
liver failure with model for end-stage liver
disease (MELD) score >15.
Ultimately, liver transplantation is the definitive
intervention which reverses the underlying liver
disease and portal hypertension which lead to
the development of hepatic hydrothorax.

Discussion

Conclusion

(continued)

In some cases of hepatic hydrothorax, chest
tubes or pleurex catheters are placed to
provide long-term access for draining the
pleural fluid. The presence of an indwelling
tube carries significant risks. Orman & Lok
reported a retrospective analysis of patient
outcomes after chest tube placement in this
context, and found that 29% developed
empyema as a complication. Current
guidelines issued by the American Society for
the Study of Liver Disease consider chest tube
placement contra-indicated for the purpose of
chronic management of hepatic hydrothorax.
When empyema does develop as a
complication of either spontaneous bacterial
empyema or as a complication secondary to
indwelling chest tube placement, management
is challenging. Patients developing this
complication by definition have advanced liver
disease, which in turn places them at high risk
for surgical interventions in general, and
decortication in particular. Although data are
limited, Chen et al reported a series of 32
cirrhotic patients undergoing thoracoscopy for
management of empyema, and observed
mortality in 21%. Kim et al reported a smaller
case series of 4 patients, with the more severe
clinical presentation matching that of the case
reported here, of cirrhotic patients with
empyema, further complicated by trapped
lung. In this case series, one of the two
patients undergoing surgical decortication
died.

This case highlights the risk of managing
hepatic hydrothorax with drainage catheters.
Additionally, the case demonstrates that
successful surgical decortication of empyema is
possible even in a decompensated cirrhotic,
and this high-risk procedure may be the critical
factor deciding OLT candidacy and long-term
survival.
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